Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | 17-Demethoxy-reblastatin |
Synonyms | |
Therapy Description |
17-demethoxy-reblastatin is a second generation HSP90 inhibitor, which may lead to decreased proliferation and increased apoptosis of tumor cells (PMID: 26323360). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
17-Demethoxy-reblastatin | 17-DR | HSP90 Inhibitor 35 | 17-demethoxy-reblastatin is a second generation HSP90 inhibitor, which may lead to decreased proliferation and increased apoptosis of tumor cells (PMID: 26323360). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|